In endometrial carcinoma, CD73 is down-regulated in carcinoma cells of poorly differentiated and advanced-stage disease, compared with normal endometrium and low-grade tumors, highlighting the protective function of CD73-derived adenosine on epithelial integrity in normal endometrium (Bowser et al., 2016). This evidence concerns the gene NT5E and endometrial carcinoma.